切换至 "中华医学电子期刊资源库"

中华细胞与干细胞杂志(电子版) ›› 2017, Vol. 07 ›› Issue (03) : 136 -140. doi: 10.3877/cma.j.issn.2095-1221.2017.03.003

所属专题: 文献

论著

自体干细胞对常规血运重建失败的重度肢体缺血患者的疗效观察
方圆1, 董智慧1,(), 魏征2, 符伟国1, 潘天岳1, 顾史洋2, 陈斌1, 郭大乔1, 徐欣1, 刘澎2, 蒋俊豪1, 杨珏1   
  1. 1. 200032 上海,复旦大学附属中山医院血管外科
    2. 200032 上海,复旦大学附属中山医院血液科
  • 收稿日期:2016-09-17 出版日期:2017-06-01
  • 通信作者: 董智慧
  • 基金资助:
    复旦大学附属中山医院人才培养计划-优秀骨干计划(2015ZSYXGG02)

Autologous stem cell transplantation in the treatment of critical limb ischemia after failure of conventional revascularization

Yuan Fang1, Zhihui Dong1,(), Zheng Wei2, Weiguo Fu1, Tianyue Pan1, Shiyang Gu2, Bin Chen1, Daqiao Guo1, Xin Xu1, Peng Liu2, Junhao Jiang1, Jue Yang1   

  1. 1. Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    2. Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
  • Received:2016-09-17 Published:2017-06-01
  • Corresponding author: Zhihui Dong
  • About author:
    Corresponding author: Dong Zhihui, Email:
引用本文:

方圆, 董智慧, 魏征, 符伟国, 潘天岳, 顾史洋, 陈斌, 郭大乔, 徐欣, 刘澎, 蒋俊豪, 杨珏. 自体干细胞对常规血运重建失败的重度肢体缺血患者的疗效观察[J/OL]. 中华细胞与干细胞杂志(电子版), 2017, 07(03): 136-140.

Yuan Fang, Zhihui Dong, Zheng Wei, Weiguo Fu, Tianyue Pan, Shiyang Gu, Bin Chen, Daqiao Guo, Xin Xu, Peng Liu, Junhao Jiang, Jue Yang. Autologous stem cell transplantation in the treatment of critical limb ischemia after failure of conventional revascularization[J/OL]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2017, 07(03): 136-140.

目的

回顾性分析自体干细胞移植治疗常规血运重建失败的重度肢体缺血患者的有效性。

方法

收集2009年5月至2015年12月复旦大学附属中山医院血管外科14例卢瑟福4 ~ 5级肢体缺血患者,术前均曾接受常规血运重建治疗,包括人工血管旁路术、动脉支架植入术等,中位年龄(48±15)岁,术后缺血无显著改善,或短期内复发。接受GCSF动员5 d后,进行外周血单个核细胞采集,获得移植物后,肌肉注射于缺血肢体。接受纯化CD34+细胞移植治疗共计11例,外周血单个核细胞移植治疗共计3例。术后12个月保肢率使用Kaplan-Meier生存分析法分析,治疗前后疼痛评分、无痛步行时间差异比较采用配对t检验。

结果

14例均获随访,平均(42±25)个月(12 ~ 74个月),1例死亡,2例截肢,死亡及截肢患者均为老年下肢动脉硬化闭塞症患者。术后2年总体生存率92.86﹪(13/14),无截肢生存率78.57﹪(11/14)。术前平均无痛步行时间(3±2)min,术后6个月(12±8)min,较术前显著改善(P < 0.05,F = 14.95)。术前平均Wong-Baker疼痛评分为7±1,平均静息痛缓解起始时间为术后(3±1)周,术后6个月疼痛评分为1±1,较术前显著改善(P < 0.05,F = 18.00)。

结论

自体干细胞移植治疗常规血运重建失败的重度肢体缺血患者安全有效。

Objective

To evaluate the efficacy of autologous stem cell transplantation in the treatment of critical limb ischemia after failure of conventional revascularization.

Methods

From May 2009 to November 2015, 14 patients with critical limb ischemia were enrolled and all of them had undergone conventional revascularization, including bypass surgery and stenting. The average age was 48±15 years (range, 21 ~ 75) . Conventional revascularization failed to improve ischemia in them. Apheresis was performed after 5-days' mobilization with GCSF to harvest stem cells. Stem cells were transplanted into the ischemic limb by intramuscular injection. Eleven patients were transplanted with purified CD34+ cells and 3 patients with peripheral blood mononuclear cells.

Results

Follow-up was accomplished in all 14 patients with an average follow-up time of (42±25) months (range 12 ~ 74) . During the follow-up there were 1 death and 2 major amputations which all occurred in aged patients with atherosclerosis obliterans. The overall survival rate 2 years after transplantation is 92.86﹪ (13/14) and the amputation free survival rate is 78.57﹪ (11/14) . The peak pain-free walking time at 6 months was significantly improved from (3±2) minutes to (12±8) minutes (P < 0.05, F = 14.95) and the Wong-Baker FACES pain rating score decreased from (7±1) to (1±1) (P < 0.05, F = 18.00) .

Conclusions

Autologous stem cell transplantation is safe and effective in treating critical limb ischemia after conventional revascularization failure.

表1 14例患者血运重建治疗史
表2 6号患者接受干细胞移植前血运重建治疗经过
表3 14例重度肢体缺血患者手术前后Wong-Baker FACES疼痛评分及无痛步行时间比较
图1 10号患者自体干细胞移植术前后患足照片
1
Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature[J]. Atherosclerosis, 2010, 209(1):10-17.
2
Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease[J]. JAMA, 2006, 295(5):547-553.
3
黄蓉,梁瑜祯,卢炳丰. 自体骨髓间充质干细胞移植促进缺血下肢血管新生的实验研究[J]. 医学研究生学报, 2015, 28(7):706-710.
4
Dong Z, Chen B, Fu W, et al. Transplantation of purified CD34+ cells in the treatment of critical limb ischemia[J]. J VascSurg, 2013, 58(2):404-411.e3.
5
董智慧,魏征,符伟国, 等. 纯化自体外周血CD34+细胞移植治疗下肢重度缺血[J]. 中华普通外科杂志, 2011, 26(3):184-187.
6
Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II)[J]. J Vasc Surg, 2007, 45 Suppl S:S5-67.
7
Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele[J]. Nature, 1996, 380(6573):435-439.
8
Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial[J]. Lancet, 2002, 360(9331):427-435.
9
Horie T, Onodera R, Akamastu M, et al. Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells[J]. Atherosclerosis, 2010, 208(2):461-466.
10
Matoba S, Tatsumi T, Murohara T, et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia[J]. Am Heart J, 2008, 156(5):1010-1018.
11
Losordo DW, Kibbe MR, Mendelsohn F, et al. A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia[J]. CircCardiovascInterv, 2012, 5(6):821-830.
12
谷涌泉,张建,齐立行, 等. 自体骨髓干细胞移植治疗慢性下肢缺血94例不同病变分期患者的效果比较[J]. 中国临床康复, 2005, 9(38):7-10.
13
Flamme I, Risau W. Induction of vasculogenesis and hematopoiesis in vitro[J]. Development, 1992, 116(2):435-439.
14
Kawamoto A, Asahara T. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies[J]. Catheter CardiovascInterv, 2007, 70(4):477-484.
15
Kawamoto A, Katayama M, Handa N, et al. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial[J]. Stem Cells, 2009, 27(11):2857-2864.
16
Saito Y, Sasaki K, Katsuda Y, et al. Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease[J]. Circ J, 2007, 71(8):1187-1192.
17
Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene[J]. Nature, 1996, 380(6573):439-442.
18
Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice[J]. Nature, 1995, 376(6535):62-66.
19
Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures[J]. Circulation, 2002, 106(22):2781-2786.
[1] 何甘霖, 陈香侬, 李萍, 甄佳怡, 李京霞, 邹外一, 许多荣. 白血病异基因造血干细胞移植术后股骨坏死的影响因素[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 450-456.
[2] 唐亦骁, 陈峻, 连正星, 胡海涛, 鲁迪, 徐骁, 卫强. 白果内酯对小鼠肝缺血再灌注损伤保护作用研究[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 278-282.
[3] 刘云, 时月, 郭冬梅, 邱志远, 王丽娟, 冉学红, 李乾鹏. 造血干细胞移植治疗伴有胚系突变的髓系肿瘤患者三例并文献复习[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 230-234.
[4] 王雪玲, 曹欢, 顾劲扬. 肠道菌群在器官缺血再灌注损伤中的作用及机制研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 247-250.
[5] 孙璐, 蒋亚玲, 陈凌君. 布托啡诺对脑缺血再灌注损伤大鼠神经炎症和JAK2/STAT3信号通路的影响[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 344-350.
[6] 王向丽, 吴涛, 毛东锋, 刘恒, 刘文慧, 周芮, 田红娟. 异基因造血干细胞移植治疗ANKRD26相关性血小板减少症1例并文献复习[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 236-238.
[7] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[8] 李京, 牛博, 刘晓蓓, 魏新雪, 黄荣. circ-SESN2 沉默靶向调控miRNA-23a-5p/ULK1 在神经细胞氧化应激损伤中的作用机制研究[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 263-272.
[9] 吉莉, 苏云楠, 王斌, 沈滔, 刘团结, 毛蕾, 徐玉萍, 张婷, 王博. 急性缺血性脑卒中患者脑白质微结构改变对长期认知功能损伤的预测价值研究[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 193-200.
[10] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[11] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[12] 梁铭垚, 袁健瑜, 关雨霏, 左思程, 阳新明, 陈巧燕. 多壳扩散磁共振成像在缺血性卒中模型的应用[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 362-368.
[13] 耿晓坤. 缺血性卒中后无效再灌注的时间窗、组织窗与神经保护[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(06): 636-636.
[14] 唐欣, 翟文海, 王润婷, 周胜宇, 靳航. 补体在缺血性卒中疾病中的研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 382-392.
[15] 董坤, 陈海恋, 王景. 血清CircRNA_0003694与老年急性缺血性卒中患者卒中后认知损害的关系[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(03): 230-235.
阅读次数
全文


摘要